ID   GUC2D_HUMAN             Reviewed;        1103 AA.
AC   Q02846; Q6LEA7;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   10-MAY-2017, entry version 195.
DE   RecName: Full=Retinal guanylyl cyclase 1;
DE            Short=RETGC-1;
DE            EC=4.6.1.2;
DE   AltName: Full=Guanylate cyclase 2D, retinal;
DE   AltName: Full=Rod outer segment membrane guanylate cyclase;
DE            Short=ROS-GC;
DE   Flags: Precursor;
GN   Name=GUCY2D; Synonyms=CORD6, GUC1A4, GUC2D, RETGC, RETGC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=1356371; DOI=10.1016/0896-6273(92)90035-C;
RA   Shyjan A.W., de Sauvage F.J., Gillett N.A., Goeddel D.V., Lowe D.G.;
RT   "Molecular cloning of a retina-specific membrane guanylyl cyclase.";
RL   Neuron 9:727-737(1992).
RN   [2]
RP   SEQUENCE REVISION.
RA   Lowe D.G.;
RL   Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Perrault I.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1009-1088.
RX   PubMed=7806240; DOI=10.1006/geno.1994.1415;
RA   Oliveira L., Miniou P., Viegas-Pequignot E., Rozet J.-M., Dollfus H.,
RA   Pittler S.J.;
RT   "Human retinal guanylate cyclase (GUC2D) maps to chromosome 17p13.1.";
RL   Genomics 22:478-481(1994).
RN   [5]
RP   3D-STRUCTURE MODELING OF 871-1028.
RX   PubMed=9391039; DOI=10.1073/pnas.94.25.13414;
RA   Liu Y., Ruoho A.E., Rao V.D., Hurley J.H.;
RT   "Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling
RT   and mutational analysis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:13414-13419(1997).
RN   [6]
RP   VARIANT LCA1 SER-52.
RX   PubMed=8944027; DOI=10.1038/ng1296-461;
RA   Perrault I., Rozet J.-M., Calvas P., Gerber S., Camuzat A.,
RA   Dollfus H., Chatelin S., Souied E., Ghazi I., Leowski C.,
RA   Bonnemaison M., le Paslier D., Frezal J., Dufier J.-L., Pittler S.,
RA   Munnich A., Kaplan J.;
RT   "Retinal-specific guanylate cyclase gene mutations in Leber's
RT   congenital amaurosis.";
RL   Nat. Genet. 14:461-464(1996).
RN   [7]
RP   VARIANT CORD6 837-ASP--MET-839.
RX   PubMed=9683616; DOI=10.1086/301985;
RA   Perrault I., Rozet J.-M., Gerber S., Kelsell R.E., Souied E.,
RA   Cabot A., Hunt D.M., Munnich A., Kaplan J.;
RT   "A retGC-1 mutation in autosomal dominant cone-rod dystrophy.";
RL   Am. J. Hum. Genet. 63:651-654(1998).
RN   [8]
RP   VARIANTS CORD6 ASP-837 AND CYS-838.
RX   PubMed=9618177; DOI=10.1093/hmg/7.7.1179;
RA   Kelsell R.E., Gregory-Evans K., Payne A.M., Perrault I., Kaplan J.,
RA   Yang R.-B., Garbers D.L., Bird A.C., Moore A.T., Hunt D.M.;
RT   "Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant
RT   cone-rod dystrophy.";
RL   Hum. Mol. Genet. 7:1179-1184(1998).
RN   [9]
RP   CHARACTERIZATION OF VARIANT LCA1 SER-565.
RX   PubMed=9888789; DOI=10.1021/bi9824137;
RA   Duda T., Venkataraman V., Goraczniak R., Lange C., Koch K.-W.,
RA   Sharma R.K.;
RT   "Functional consequences of a rod outer segment membrane guanylate
RT   cyclase (ROS-GC1) gene mutation linked with Leber's congenital
RT   amaurosis.";
RL   Biochemistry 38:509-515(1999).
RN   [10]
RP   VARIANTS LCA1 TYR-105; PRO-325 AND SER-858.
RX   PubMed=11035546; DOI=10.1076/1381-6810(200009)2131-ZFT135;
RA   Dharmaraj S.R., Silva E.R., Pina A.-L., Li Y.Y., Yang J.M.,
RA   Carter C.R., Loyer M.K., El-Hilali H.K., Traboulsi E.K., Sundin O.K.,
RA   Zhu D.K., Koenekoop R.K., Maumenee I.H.;
RT   "Mutational analysis and clinical correlation in Leber congenital
RT   amaurosis.";
RL   Ophthalmic Genet. 21:135-150(2000).
RN   [11]
RP   VARIANT LCA1 PRO-954.
RX   PubMed=12365911; DOI=10.1001/archopht.120.10.1325;
RA   Koenekoop R.K., Fishman G.A., Iannaccone A., Ezzeldin H.,
RA   Ciccarelli M.L., Baldi A., Sunness J.S., Lotery A.J., Jablonski M.M.,
RA   Pittler S.J., Maumenee I.;
RT   "Electroretinographic abnormalities in parents of patients with Leber
RT   congenital amaurosis who have heterozygous GUCY2D mutations.";
RL   Arch. Ophthalmol. 120:1325-1330(2002).
RN   [12]
RP   VARIANTS CORD6 CYS-838 AND HIS-838, AND DISCUSSION OF PHENOTYPIC
RP   VARIABILITY.
RX   PubMed=12552567; DOI=10.1002/humu.9109;
RA   Udar N., Yelchits S., Chalukya M., Yellore V., Nusinowitz S.,
RA   Silva-Garcia R., Vrabec T., Hussles Maumenee I., Donoso L.,
RA   Small K.W.;
RT   "Identification of GUCY2D gene mutations in CORD5 families and
RT   evidence of incomplete penetrance.";
RL   Hum. Mutat. 21:170-171(2003).
RN   [13]
RP   INVOLVEMENT IN CORD6.
RX   PubMed=15111605; DOI=10.1167/iovs.03-0315;
RA   Ito S., Nakamura M., Nuno Y., Ohnishi Y., Nishida T., Miyake Y.;
RT   "Novel complex GUCY2D mutation in Japanese family with cone-rod
RT   dystrophy.";
RL   Invest. Ophthalmol. Vis. Sci. 45:1480-1485(2004).
RN   [14]
RP   CHARACTERIZATION OF VARIANTS LCA1 TYR-105; PRO-325; SER-858 AND
RP   PRO-954.
RX   PubMed=15123990;
RA   Tucker C.L., Ramamurthy V., Pina A.-L., Loyer M., Dharmaraj S., Li Y.,
RA   Maumenee I.H., Hurley J.B., Koenekoop R.K.;
RT   "Functional analyses of mutant recessive GUCY2D alleles identified in
RT   Leber congenital amaurosis patients: protein domain comparisons and
RT   dominant negative effects.";
RL   Mol. Vis. 10:297-303(2004).
RN   [15]
RP   POSSIBLE INVOLVEMENT OF VARIANT SER-701 IN LEBER CONGENITAL AMAUROSIS.
RX   PubMed=16123401; DOI=10.1167/iovs.05-0111;
RA   Zernant J., Kulm M., Dharmaraj S., den Hollander A.I., Perrault I.,
RA   Preising M.N., Lorenz B., Kaplan J., Cremers F.P., Maumenee I.,
RA   Koenekoop R.K., Allikmets R.;
RT   "Genotyping microarray (disease chip) for Leber congenital amaurosis:
RT   detection of modifier alleles.";
RL   Invest. Ophthalmol. Vis. Sci. 46:3052-3059(2005).
RN   [16]
RP   VARIANTS LCA1 TRP-768 AND GLN-795, VARIANTS ARG-325 AND SER-701, AND
RP   POSSIBLE INVOLVEMENT OF VARIANT SER-701 IN LEBER CONGENITAL AMAUROSIS.
RX   PubMed=17724218; DOI=10.1167/iovs.07-0068;
RA   Simonelli F., Ziviello C., Testa F., Rossi S., Fazzi E., Bianchi P.E.,
RA   Fossarello M., Signorini S., Bertone C., Galantuomo S., Brancati F.,
RA   Valente E.M., Ciccodicola A., Rinaldi E., Auricchio A., Banfi S.;
RT   "Clinical and molecular genetics of Leber's congenital amaurosis: a
RT   multicenter study of Italian patients.";
RL   Invest. Ophthalmol. Vis. Sci. 48:4284-4290(2007).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-328; ASP-431; MET-507; GLU-693;
RP   SER-701 AND HIS-782.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [18]
RP   INVOLVEMENT IN CORD6.
RX   PubMed=18332321; DOI=10.1001/archopht.126.3.397;
RA   Small K.W., Silva-Garcia R., Udar N., Nguyen E.V., Heckenlively J.R.;
RT   "New mutation, P575L, in the GUCY2D gene in a family with autosomal
RT   dominant progressive cone degeneration.";
RL   Arch. Ophthalmol. 126:397-403(2008).
RN   [19]
RP   INVOLVEMENT IN CORD6, AND VARIANTS CORD6 CYS-838; HIS-838 AND GLY-838.
RX   PubMed=18487367; DOI=10.1167/iovs.08-1901;
RA   Kitiratschky V.B., Wilke R., Renner A.B., Kellner U., Vadala M.,
RA   Birch D.G., Wissinger B., Zrenner E., Kohl S.;
RT   "Mutation analysis identifies GUCY2D as the major gene responsible for
RT   autosomal dominant progressive cone degeneration.";
RL   Invest. Ophthalmol. Vis. Sci. 49:5015-5023(2008).
RN   [20]
RP   INVOLVEMENT IN CORD6, AND VARIANT CORD6 THR-949.
RX   PubMed=20517349; DOI=10.1038/ejhg.2010.81;
RA   Ugur Iseri S.A., Durlu Y.K., Tolun A.;
RT   "A novel recessive GUCY2D mutation causing cone-rod dystrophy and not
RT   Leber's congenital amaurosis.";
RL   Eur. J. Hum. Genet. 18:1121-1126(2010).
RN   [21]
RP   VARIANT CORD6 PRO-838.
RX   PubMed=21552474;
RA   Garcia-Hoyos M., Auz-Alexandre C.L., Almoguera B., Cantalapiedra D.,
RA   Riveiro-Alvarez R., Lopez-Martinez M.A., Gimenez A., Blanco-Kelly F.,
RA   Avila-Fernandez A., Trujillo-Tiebas M.J., Garcia-Sandoval B.,
RA   Ramos C., Ayuso C.;
RT   "Mutation analysis at codon 838 of the Guanylate Cyclase 2D gene in
RT   Spanish families with autosomal dominant cone, cone-rod, and macular
RT   dystrophies.";
RL   Mol. Vis. 17:1103-1109(2011).
RN   [22]
RP   VARIANT CORD6 HIS-838.
RX   PubMed=22194653;
RA   Xiao X., Guo X., Jia X., Li S., Wang P., Zhang Q.;
RT   "A recurrent mutation in GUCY2D associated with autosomal dominant
RT   cone dystrophy in a Chinese family.";
RL   Mol. Vis. 17:3271-3278(2011).
RN   [23]
RP   VARIANTS LCA1 MET-55; VAL-103; MET-312; 405-PRO-ASN-406; CYS-438;
RP   LEU-640; GLN-660; HIS-728; ALA-734; TRP-768; ARG-784 AND LEU-1007;
RP   GLY-ILE-1027 INS, AND VARIANTS ARG-21; SER-52 AND SER-701.
RX   PubMed=21602930; DOI=10.1371/journal.pone.0019458;
RA   Li L., Xiao X., Li S., Jia X., Wang P., Guo X., Jiao X., Zhang Q.,
RA   Hejtmancik J.F.;
RT   "Detection of variants in 15 genes in 87 unrelated Chinese patients
RT   with Leber congenital amaurosis.";
RL   PLoS ONE 6:E19458-E19458(2011).
RN   [24]
RP   VARIANT CORD6 ALA-849.
RX   PubMed=23734073;
RA   Zhao X., Ren Y., Zhang X., Chen C., Dong B., Li Y.;
RT   "A novel GUCY2D mutation in a Chinese family with dominant cone
RT   dystrophy.";
RL   Mol. Vis. 19:1039-1046(2013).
RN   [25]
RP   VARIANT CORD6 HIS-838.
RX   PubMed=24480840; DOI=10.1038/eye.2014.7;
RA   Mukherjee R., Robson A.G., Holder G.E., Stockman A., Egan C.A.,
RA   Moore A.T., Webster A.R.;
RT   "A detailed phenotypic description of autosomal dominant cone
RT   dystrophy due to a de novo mutation in the GUCY2D gene.";
RL   Eye 28:481-487(2014).
CC   -!- FUNCTION: Probably plays a specific functional role in the rods
CC       and/or cones of photoreceptors. It may be the enzyme involved in
CC       the resynthesis of cGMP required for recovery of the dark state
CC       after phototransduction.
CC   -!- CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.
CC   -!- ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Retina. Localized exclusively in the nuclei
CC       and inner segments of the rod and cone photoreceptor cells.
CC   -!- DISEASE: Leber congenital amaurosis 1 (LCA1) [MIM:204000]: A
CC       severe dystrophy of the retina, typically becoming evident in the
CC       first years of life. Visual function is usually poor and often
CC       accompanied by nystagmus, sluggish or near-absent pupillary
CC       responses, photophobia, high hyperopia and keratoconus.
CC       {ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:12365911,
CC       ECO:0000269|PubMed:15123990, ECO:0000269|PubMed:17724218,
CC       ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:8944027,
CC       ECO:0000269|PubMed:9888789}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cone-rod dystrophy 6 (CORD6) [MIM:601777]: An inherited
CC       retinal dystrophy characterized by retinal pigment deposits
CC       visible on fundus examination, predominantly in the macular
CC       region, and initial loss of cone photoreceptors followed by rod
CC       degeneration. This leads to decreased visual acuity and
CC       sensitivity in the central visual field, followed by loss of
CC       peripheral vision. Severe loss of vision occurs earlier than in
CC       retinitis pigmentosa, due to cone photoreceptors degenerating at a
CC       higher rate than rod photoreceptors. {ECO:0000269|PubMed:12552567,
CC       ECO:0000269|PubMed:15111605, ECO:0000269|PubMed:18332321,
CC       ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:20517349,
CC       ECO:0000269|PubMed:21552474, ECO:0000269|PubMed:22194653,
CC       ECO:0000269|PubMed:23734073, ECO:0000269|PubMed:24480840,
CC       ECO:0000269|PubMed:9618177, ECO:0000269|PubMed:9683616}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -!- WEB RESOURCE: Name=Mutations of the GUCY2D gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/gcmut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M92432; AAA60547.1; -; mRNA.
DR   EMBL; AJ222657; CAA10914.1; -; Genomic_DNA.
DR   EMBL; L26921; AAA60366.1; -; Genomic_DNA.
DR   CCDS; CCDS11127.1; -.
DR   PIR; JH0717; JH0717.
DR   RefSeq; NP_000171.1; NM_000180.3.
DR   RefSeq; XP_011522118.1; XM_011523816.1.
DR   UniGene; Hs.592109; -.
DR   PDB; 1AWL; Model; -; A/B=871-1028.
DR   PDBsum; 1AWL; -.
DR   ProteinModelPortal; Q02846; -.
DR   SMR; Q02846; -.
DR   BioGrid; 109255; 2.
DR   IntAct; Q02846; 2.
DR   MINT; MINT-7241905; -.
DR   STRING; 9606.ENSP00000254854; -.
DR   TCDB; 8.A.85.1.3; the guanylate cyclase (gc) family.
DR   iPTMnet; Q02846; -.
DR   PhosphoSitePlus; Q02846; -.
DR   BioMuta; GUCY2D; -.
DR   DMDM; 1345920; -.
DR   MaxQB; Q02846; -.
DR   PaxDb; Q02846; -.
DR   PeptideAtlas; Q02846; -.
DR   PRIDE; Q02846; -.
DR   DNASU; 3000; -.
DR   Ensembl; ENST00000254854; ENSP00000254854; ENSG00000132518.
DR   GeneID; 3000; -.
DR   KEGG; hsa:3000; -.
DR   UCSC; uc002gjt.3; human.
DR   CTD; 3000; -.
DR   DisGeNET; 3000; -.
DR   GeneCards; GUCY2D; -.
DR   GeneReviews; GUCY2D; -.
DR   HGNC; HGNC:4689; GUCY2D.
DR   MalaCards; GUCY2D; -.
DR   MIM; 204000; phenotype.
DR   MIM; 600179; gene.
DR   MIM; 601777; phenotype.
DR   neXtProt; NX_Q02846; -.
DR   OpenTargets; ENSG00000132518; -.
DR   Orphanet; 75377; Central areolar choroidal dystrophy.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   Orphanet; 65; Leber congenital amaurosis.
DR   PharmGKB; PA187; -.
DR   eggNOG; KOG1023; Eukaryota.
DR   eggNOG; COG2114; LUCA.
DR   GeneTree; ENSGT00760000118959; -.
DR   HOGENOM; HOG000293307; -.
DR   HOVERGEN; HBG098487; -.
DR   InParanoid; Q02846; -.
DR   KO; K12321; -.
DR   OMA; AMLELTP; -.
DR   OrthoDB; EOG091G00VM; -.
DR   PhylomeDB; Q02846; -.
DR   TreeFam; TF106338; -.
DR   BRENDA; 4.6.1.2; 2681.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   GenomeRNAi; 3000; -.
DR   PRO; PR:Q02846; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000132518; -.
DR   CleanEx; HS_GUCY2D; -.
DR   Genevisible; Q02846; HS.
DR   GO; GO:0008074; C:guanylate cyclase complex, soluble; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005640; C:nuclear outer membrane; TAS:ProtInc.
DR   GO; GO:0097381; C:photoreceptor disc membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   Gene3D; 3.30.70.1230; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR011645; HNOB_dom_associated.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07701; HNOBA; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cGMP biosynthesis; Complete proteome;
KW   Cone-rod dystrophy; Disease mutation; Disulfide bond; Glycoprotein;
KW   GTP-binding; Leber congenital amaurosis; Lyase; Membrane;
KW   Nucleotide-binding; Polymorphism; Reference proteome;
KW   Sensory transduction; Signal; Transmembrane; Transmembrane helix;
KW   Vision.
FT   SIGNAL        1     51       {ECO:0000255}.
FT   CHAIN        52   1103       Retinal guanylyl cyclase 1.
FT                                /FTId=PRO_0000012381.
FT   TOPO_DOM     52    462       Extracellular. {ECO:0000255}.
FT   TRANSMEM    463    487       Helical. {ECO:0000255}.
FT   TOPO_DOM    488   1103       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      525    808       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      880   1010       Guanylate cyclase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    449    449       Interchain. {ECO:0000305}.
FT   DISULFID    457    457       Interchain. {ECO:0000305}.
FT   VARIANT      21     21       W -> R (in dbSNP:rs9905402).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067168.
FT   VARIANT      52     52       A -> S (in LCA1; unknown pathological
FT                                significance; dbSNP:rs61749665).
FT                                {ECO:0000269|PubMed:21602930,
FT                                ECO:0000269|PubMed:8944027}.
FT                                /FTId=VAR_003435.
FT   VARIANT      55     55       T -> M (in LCA1; dbSNP:rs201414567).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067169.
FT   VARIANT     103    103       E -> V (in LCA1).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067170.
FT   VARIANT     105    105       C -> Y (in LCA1; does not affect basal
FT                                activity; reduces GCAP-1 induced
FT                                activity; dbSNP:rs61749669).
FT                                {ECO:0000269|PubMed:11035546,
FT                                ECO:0000269|PubMed:15123990}.
FT                                /FTId=VAR_023770.
FT   VARIANT     312    312       T -> M (in LCA1; dbSNP:rs61749673).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067171.
FT   VARIANT     325    325       L -> P (in LCA1; does not affect basal
FT                                activity; reduces GCAP-1 induced
FT                                activity; dbSNP:rs61749675).
FT                                {ECO:0000269|PubMed:11035546,
FT                                ECO:0000269|PubMed:15123990}.
FT                                /FTId=VAR_023771.
FT   VARIANT     325    325       L -> R (found in a patient with LCA1).
FT                                {ECO:0000269|PubMed:17724218}.
FT                                /FTId=VAR_067172.
FT   VARIANT     328    328       A -> V (in dbSNP:rs56280231).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042229.
FT   VARIANT     331    331       R -> S (in dbSNP:rs34596269).
FT                                /FTId=VAR_049254.
FT   VARIANT     362    362       A -> S (in LCA1; dbSNP:rs61749677).
FT                                /FTId=VAR_009129.
FT   VARIANT     405    406       LD -> PN (in LCA1).
FT                                /FTId=VAR_067173.
FT   VARIANT     431    431       G -> D (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042230.
FT   VARIANT     438    438       R -> C (in LCA1; dbSNP:rs565948960).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067174.
FT   VARIANT     507    507       V -> M (in dbSNP:rs746002871).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042231.
FT   VARIANT     565    565       F -> S (in LCA1; loss of activity;
FT                                dbSNP:rs61749755).
FT                                {ECO:0000269|PubMed:9888789}.
FT                                /FTId=VAR_009131.
FT   VARIANT     573    573       I -> V (in LCA1; dbSNP:rs61749756).
FT                                /FTId=VAR_009130.
FT   VARIANT     602    602       R -> W (in dbSNP:rs34331388).
FT                                /FTId=VAR_049255.
FT   VARIANT     640    640       W -> L (in LCA1).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067175.
FT   VARIANT     660    660       R -> Q (in LCA1; dbSNP:rs61750162).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067176.
FT   VARIANT     693    693       A -> E (in dbSNP:rs35146471).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042232.
FT   VARIANT     701    701       P -> S (polymorphism that at homozygosity
FT                                may be associated with Leber congenital
FT                                amaurosis in some populations;
FT                                dbSNP:rs34598902).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:17724218,
FT                                ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_009132.
FT   VARIANT     722    722       R -> W (in dbSNP:rs34331388).
FT                                /FTId=VAR_049256.
FT   VARIANT     728    728       D -> H (in LCA1).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067177.
FT   VARIANT     734    734       I -> A (in LCA1; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067178.
FT   VARIANT     768    768       R -> W (in LCA1; dbSNP:rs61750168).
FT                                {ECO:0000269|PubMed:17724218,
FT                                ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067179.
FT   VARIANT     782    782       L -> H (rare polymorphism;
FT                                dbSNP:rs8069344).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_009133.
FT   VARIANT     784    784       M -> R (in LCA1).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067180.
FT   VARIANT     795    795       R -> Q (in LCA1; dbSNP:rs61750171).
FT                                {ECO:0000269|PubMed:17724218}.
FT                                /FTId=VAR_067181.
FT   VARIANT     837    839       ERT -> DCM (in CORD6).
FT                                /FTId=VAR_003438.
FT   VARIANT     837    837       E -> D (in CORD6; dbSNP:rs28933695).
FT                                {ECO:0000269|PubMed:9618177}.
FT                                /FTId=VAR_003436.
FT   VARIANT     838    838       R -> C (in CORD6; dbSNP:rs61750172).
FT                                {ECO:0000269|PubMed:12552567,
FT                                ECO:0000269|PubMed:18487367,
FT                                ECO:0000269|PubMed:9618177}.
FT                                /FTId=VAR_003437.
FT   VARIANT     838    838       R -> G (in CORD6).
FT                                {ECO:0000269|PubMed:18487367}.
FT                                /FTId=VAR_071605.
FT   VARIANT     838    838       R -> H (in CORD6; dbSNP:rs61750173).
FT                                {ECO:0000269|PubMed:12552567,
FT                                ECO:0000269|PubMed:18487367,
FT                                ECO:0000269|PubMed:22194653,
FT                                ECO:0000269|PubMed:24480840}.
FT                                /FTId=VAR_015373.
FT   VARIANT     838    838       R -> P (in CORD6).
FT                                {ECO:0000269|PubMed:21552474}.
FT                                /FTId=VAR_071606.
FT   VARIANT     849    849       T -> A (in CORD6).
FT                                {ECO:0000269|PubMed:23734073}.
FT                                /FTId=VAR_071607.
FT   VARIANT     858    858       P -> S (in LCA1; severely impairs basal
FT                                and GCAP-1 induced activity;
FT                                dbSNP:rs61750176).
FT                                {ECO:0000269|PubMed:11035546,
FT                                ECO:0000269|PubMed:15123990}.
FT                                /FTId=VAR_009134.
FT   VARIANT     949    949       I -> T (in CORD6; dbSNP:rs267606857).
FT                                {ECO:0000269|PubMed:20517349}.
FT                                /FTId=VAR_071608.
FT   VARIANT     954    954       L -> P (in LCA1; severely impairs basal
FT                                and GCAP-1 induced activity;
FT                                dbSNP:rs61750182).
FT                                {ECO:0000269|PubMed:12365911,
FT                                ECO:0000269|PubMed:15123990}.
FT                                /FTId=VAR_009135.
FT   VARIANT    1007   1007       S -> L (in LCA1).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067182.
FT   VARIANT    1027   1027       I -> IGI (in LCA1).
FT                                /FTId=VAR_067183.
SQ   SEQUENCE   1103 AA;  120059 MW;  28631557E7CBDFA4 CRC64;
     MTACARRAGG LPDPGLCGPA WWAPSLPRLP RALPRLPLLL LLLLLQPPAL SAVFTVGVLG
     PWACDPIFSR ARPDLAARLA AARLNRDPGL AGGPRFEVAL LPEPCRTPGS LGAVSSALAR
     VSGLVGPVNP AACRPAELLA EEAGIALVPW GCPWTQAEGT TAPAVTPAAD ALYALLRAFG
     WARVALVTAP QDLWVEAGRS LSTALRARGL PVASVTSMEP LDLSGAREAL RKVRDGPRVT
     AVIMVMHSVL LGGEEQRYLL EAAEELGLTD GSLVFLPFDT IHYALSPGPE ALAALANSSQ
     LRRAHDAVLT LTRHCPSEGS VLDSLRRAQE RRELPSDLNL QQVSPLFGTI YDAVFLLARG
     VAEARAAAGG RWVSGAAVAR HIRDAQVPGF CGDLGGDEEP PFVLLDTDAA GDRLFATYML
     DPARGSFLSA GTRMHFPRGG SAPGPDPSCW FDPNNICGGG LEPGLVFLGF LLVVGMGLAG
     AFLAHYVRHR LLHMQMVSGP NKIILTVDDI TFLHPHGGTS RKVAQGSRSS LGARSMSDIR
     SGPSQHLDSP NIGVYEGDRV WLKKFPGDQH IAIRPATKTA FSKLQELRHE NVALYLGLFL
     ARGAEGPAAL WEGNLAVVSE HCTRGSLQDL LAQREIKLDW MFKSSLLLDL IKGIRYLHHR
     GVAHGRLKSR NCIVDGRFVL KITDHGHGRL LEAQKVLPEP PRAEDQLWTA PELLRDPALE
     RRGTLAGDVF SLAIIMQEVV CRSAPYAMLE LTPEEVVQRV RSPPPLCRPL VSMDQAPVEC
     ILLMKQCWAE QPELRPSMDH TFDLFKNINK GRKTNIIDSM LRMLEQYSSN LEDLIRERTE
     ELELEKQKTD RLLTQMLPPS VAEALKTGTP VEPEYFEQVT LYFSDIVGFT TISAMSEPIE
     VVDLLNDLYT LFDAIIGSHD VYKVETIGDA YMVASGLPQR NGQRHAAEIA NMSLDILSAV
     GTFRMRHMPE VPVRIRIGLH SGPCVAGVVG LTMPRYCLFG DTVNTASRME STGLPYRIHV
     NLSTVGILRA LDSGYQVELR GRTELKGKGA EDTFWLVGRR GFNKPIPKPP DLQPGSSNHG
     ISLQEIPPER RRKLEKARPG QFS
//
